Skip to content

Immune Profile of Acute VKH Patients PBMC

Clinical Observational Research on Changes of Peripheral Blood Mononuclear Cell(PBMC) Immunity and Expression Profile in Peripheral Blood of Different Course of of Vogt-Hoyanagi-Harada(VKH) Patients.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04025476
Acronym
IPV
Enrollment
48
Registered
2019-07-19
Start date
2019-07-20
Completion date
2022-07-07
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VKH Syndrome

Keywords

VKH; immune profile;

Brief summary

The investigators will collect blood samples of different courses of VKH patients for investigating immune profile, observe major immune cells number ,functional and membrane molecular changes in the course of treatment, to investigate pathogenesis of VKH. Meanwhile, the investigators will collect clinical data of VKH patients to observe choroid and retina change in different courses.

Interventions

DRUGSteroids

IV and oral steroids

Sponsors

Aier School of Ophthalmology, Central South University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Acute VKH patients, meet a criterion of VKH, no recurrence. 2. Age range from 18 to 50 years old.

Exclusion criteria

1. Patients with Severe Cardiovascular and Cerebrovascular Diseases 2. Patients allergic to steroid or contrast agents; 3. A history of ocular trauma or intraocular surgery within 3 months; Vaccinated; History of infectious diseases 4. having a history of heredity, immune system correlation, neuroendocrine and digestive system diseases 5. Patients who take health care products for a long time and have heavy alcohol and tobacco addiction.

Design outcomes

Primary

MeasureTime frameDescription
T/B /NK(natural killer )/monocyte...etc, cell numbers of blood samples in VKH patientsone yearuse flow cytometry to count T/B /NK/monocyte...etc, cell numbers
T/B /NK/monocyte...etc cell subtype proportion in blood samples in VKH patientsone yearuse flow cytometry to measure T/B /NK/monocyte...etc cell subtype proportion
T/B /NK/monocyte...etc cell functional change in VKH patientsone yearuse ELISA(enzyme linked immunosorbent assay) to measure inflammatory cytokines level in peripheral blood

Secondary

MeasureTime frameDescription
choroid and retinal thickness change in different course of VKH patientsone yearUse OCT(optical coherence tomography) to measure choroid and retina thickness changes in macular zone of different course VKH patients
measure the Injury degree of choroid and retinal vesselsone yearUse FFA(fluorescein fundus angiography)/ICG(Indocyanine Green Angiography) to measure the Injury degree of choroid and retinal vessels
Use OCTA(optical coherence tomography angiography) to measure macular and optic disc vascular indexone yearUse OCTA to measure macular and optic disc vascular index in different course VKH patients
Use Maia perimeter to measure macular integralityone yearUse Maia perimeter to measure macular integrality including light threshold and central fixation.

Countries

China

Contacts

Primary ContactZhaohui Li, Ph.D/MD
lizhaohui@whu.edu.cn+86-186-2790-1441
Backup ContactYafei Huang, Ph.d
huangyf@tjh.tjmu.edu.cn+86-136-2862-7928

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026